Session » Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Date: Tuesday, November 12, 2019

Time: 9:00AM-11:00AM

Meeting: 2019 ACR/ARP Annual Meeting

9:00AM-11:00AM: Abstract Number: 2218

1,25D3 Promotes Mineralization of Osteoblasts by Activating C/EBPβ-DKK1 Axis

9:00AM-11:00AM: Abstract Number: 2220

Abaloparatide Followed by Alendronate on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis

9:00AM-11:00AM: Abstract Number: 2230

Applicability of FRAX in Clinical Practice: 10-year Results

9:00AM-11:00AM: Abstract Number: 2214

Assessment of Bone Quality by Trabecular Bone Score (TBS) in Systemic Lupus Erythematosus Patients

9:00AM-11:00AM: Abstract Number: 2223

Attenuated Association Between Proton Pump Inhibitor Use and Fracture Risk After Consideration of Chronic Comorbidities

9:00AM-11:00AM: Abstract Number: 2222

Bone Health: An Independent Predictor of Coronary Artery Disease

9:00AM-11:00AM: Abstract Number: 2221

Bone Metabolism Impairment in Heart Transplant: Results from a Prospective Cohort Study

9:00AM-11:00AM: Abstract Number: 2207

Bone Mineral Density and Microarchitecture Among Chinese Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2216

Bone Mineral Density of the Spine, Hip, and Distal Radius in Patients with Postmenopausal Osteoporosis

9:00AM-11:00AM: Abstract Number: 2227

Can We Predict Hypophosphatasia-Mutation Result Based on Alkaline Phosphatase Serum Levels?

9:00AM-11:00AM: Abstract Number: 2217

DEXA Does Not Accurately Reflect FRAX Score in Patients with Autoimmune Disease on Corticosteroids

9:00AM-11:00AM: Abstract Number: 2229

Differences in Fracture Risk Assessment (FRAX) and Osteoporosis Treatment Cutoffs with and Without Bone Mineral Density Are Greater in Anti-Cyclic Citrullinated Peptide Positive Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 2205

Dual Femur Bone Density Measurements with Novel Sonographic Approach – Radiofrequency Echographic Multi Spectrometry

9:00AM-11:00AM: Abstract Number: 2213

Evaluation of Factors Associated with Bone Structure in an SLE Cohort Measured by Clinical 3T MRI and DEXA

9:00AM-11:00AM: Abstract Number: 2226

Factors Contributing to Fracture in Pernicious Anemia Patients Presenting with Symptomatic Subacute Vertebral Compression Fractures

9:00AM-11:00AM: Abstract Number: 2204

Fragility Fractures in a Community Setting: Clinical Characteristics, Care Gaps, and Outcomes

9:00AM-11:00AM: Abstract Number: 2233

Hip Fracture Incidence in a Teaching Hospital: Intervention for the Prevention of Second Hip Fracture

9:00AM-11:00AM: Abstract Number: 2231

Improving Compliance with Screening for Osteoporosis in Elderly Women

9:00AM-11:00AM: Abstract Number: 2208

Mediators of Bone Metabolism (DKK1, OPG, Sclerostin and RANKL) in a Cohort of Patients with Elderly-onset Arthritis

9:00AM-11:00AM: Abstract Number: 2215

Modeling-Based Bone Formation Persists in the Femoral Neck Despite Remodeling Inhibition in Subjects Treated with Denosumab

9:00AM-11:00AM: Abstract Number: 2206

MRI-based Textural Analysis of Trabecular Bone: A Novel Method for the Opportunistic Screening of Bone Quality

9:00AM-11:00AM: Abstract Number: 2234

Osteoporosis Screening in a Resident-Driven Clinic of a Large Academic Hospital

9:00AM-11:00AM: Abstract Number: 2224

Parkinson’s Disease and Risk of Fractures : A Meta Analysis of Cohort Studies

9:00AM-11:00AM: Abstract Number: 2212

Patients with Axial Spondyloarthritis Have Abnormal Microarchitecture Despite Normal Areal Bone Mineral Density and Trabecular Bone Score by DXA

9:00AM-11:00AM: Abstract Number: 2219

Randomized Control Study in Glucocorticoid-Induced Osteoporosis Treated with Bisphosphonate or Denosumab (GOBID)

9:00AM-11:00AM: Abstract Number: 2210

Relationship Between Structural Spine Involvement and the Scanographic Bone Attenuation Coefficient of L1 in a Population of 73 Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 2232

Results of the Implementation of a Bone Health Program in Patients with Rheumatoid Arthritis to Improve the Evaluation of Osteoporosis

9:00AM-11:00AM: Abstract Number: 2228

Rheumatoid Arthritis Disease Activity Is Associated with Low Femoral Neck Bone Mineral Density in a Diverse Cohort of Patients

9:00AM-11:00AM: Abstract Number: 2209

Study of Vertebral Fracture Prevalence and Scanographic Bone Attenuation Coefficient of the First Lumbar Vertebra (SBAC-L1) in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis vs. Controls

9:00AM-11:00AM: Abstract Number: 2225

Systematic Osteoporosis Screening in Chronic Obtructive Pulmonary Disease (Study of Correlation Between Pulmonary Functions Tests and Bone Parameters): Emphysematous Status Is Linked to Low Bone Density and Osteoporosis

9:00AM-11:00AM: Abstract Number: 2211

What Are the Consequences of Spinal Ankylosis on the Bone Trabecular Fragility Assessed on CT- scan in Patients with Ankylosing Spondylitis?

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].